Published: 18 July 2016
Author(s): Daniela Kampmeyer, Hendrik Lehnert, Heiner Moenig, Christian S. Haas, Birgit Harbeck
Issue: July 2016
Section: Letter to the Editor

Patients with adrenal insufficiency (AI) require continuous glucocorticoid (GC) replacement treatment to restore well-being and to prevent life-threatening complications. Knowledge of symptoms of inadequate replacement and on therapeutic options is of utmost importance to provide best medical care. We previously demonstrated significant differences between physicians working at Hospitals with and without a Division of Endocrinology when asked about knowledge of clinical signs and treatment of AI [1].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.